B7-H4 EXPRESSION ID'S A SUPPRESSIVE MACROPHAGE POPULATION IN OVARIAN CARCINOMA
B7-H4 EXPRESSION ID'S A SUPPRESSIVE MACROPHAGE POPULATION IN OVARIAN CARCINOMA
批准号:
7562386
负责人:
I KRYCZEK
金额:
$3.04万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-05-01 至 2008-04-30
关键词:
Computer Retrieval of Information on Scientific Projects DatabaseDisease regressionEctopic ExpressionFamilyFundingGrantGranulocyte-Macrophage Colony-Stimulating FactorImmune responseImmunityInstitutionInterleukin-10Interleukin-4Interleukin-6Malignant NeoplasmsMalignant neoplasm of ovaryOvarian CarcinomaPopulationResearchResearch PersonnelResourcesSourceSuppressor-Effector T-LymphocytesSurfaceT-LymphocyteTumor AntigensTumor ImmunityUnited States National Institutes of Healtharginasecytokinehuman NOS2A proteinin vivomacrophageneoplastic cellnovelnovel strategiesovarian neoplasmtumortumor progression
中文摘要
这个子项目是许多研究子项目中利用
资源由NIH/NCRR资助的中心拨款提供。子项目和
调查员(PI)可能从NIH的另一个来源获得了主要资金,
并因此可以在其他清晰的条目中表示。列出的机构是
该中心不一定是调查人员的机构。
肿瘤相关巨噬细胞是卵巢癌间质的重要组成部分,与肿瘤的进展密切相关。B7-H4是新近发现的一种B7家族分子。我们发现,原代卵巢肿瘤细胞表达细胞内B7-H4,而部分肿瘤巨噬细胞表达表面B7-H4。B7-H4+肿瘤巨噬细胞,而不是原代卵巢肿瘤细胞,抑制肿瘤相关抗原特异性T细胞免疫。阻断B7-H4-,而不是精氨酸酶-诱导型一氧化氮合酶或B7-H1可恢复巨噬细胞的T细胞刺激能力,并有助于体内肿瘤的消退。白介素6和白介素10在肿瘤微环境中含量较高。这些细胞因子刺激巨噬细胞B7-H4的表达。相反,限制在肿瘤微环境中的粒细胞/巨噬细胞集落刺激因子和IL-4抑制B7-H4的表达。B7-H4的异位表达使正常巨噬细胞受到抑制。因此,B7-H4+肿瘤巨噬细胞构成了卵巢癌中一种新的抑制细胞群。在卵巢癌中,B7-H4的表达在决定宿主对功能失调的细胞因子的反应中是一个关键的检查点。阻断B7-H4或清除B7-H4+肿瘤巨噬细胞可能是增强肿瘤T细胞肿瘤免疫的新策略。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Tumor-associated macrophages are a prominent component of ovarian cancer stroma and contribute to tumor progression. B7-H4 is a recently identified B7 family molecule. We show that primary ovarian tumor cells express intracellular B7-H4, whereas a fraction of tumor macrophages expresses surface B7-H4. B7-H4+ tumor macrophages, but not primary ovarian tumor cells, suppress tumor-associated antigen-specific T cell immunity. Blocking B7-H4-, but not arginase-, inducible nitric oxide synthase or B7-H1 restored the T cell stimulating capacity of the macrophages and contributes to tumor regression in vivo. Interleukin (IL)-6 and IL-10 are found in high concentrations in the tumor microenvironment. These cytokines stimulate macrophage B7-H4 expression. In contrast, granulocyte/macrophage colony-stimulating factor and IL-4, which are limited in the tumor microenvironment, inhibit B7-H4 expression. Ectopic expression of B7-H4 makes normal macrophages suppressive. Thus, B7-H4+ tumor macrophages constitute a novel suppressor cell population in ovarian cancer. B7-H4 expression represents a critical checkpoint in determining host responses to dysfunctional cytokines in ovarian cancer. Blocking B7-H4 or depleting B7-H4+ tumor macrophages may represent novel strategies to enhance T cell tumor immunity in cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CXCL12 AND VEGF SYNERGISTICALLY INDUCE NEOANGIOGENESIS IN HUMAN OVARIAN CANCERS
-
批准号:7562354
-
项目类别:
-
资助金额:$3.04万
-
财政年份:2007
-
负责人:I KRYCZEK
-
依托单位:
CXCL12 AND VEGF SYNERGISTICALLY INDUCE NEOANGIOGENESIS IN HUMAN OVARIAN CANCERS
-
批准号:7349120
-
项目类别:
-
资助金额:$3.1万
-
财政年份:2006
-
负责人:I KRYCZEK
-
依托单位:
海外基金